ASX - By Stock
|
MSB |
Re:
Bitter Pill
|
|
Medicalcentral
|
246 |
85K |
19 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
246
|
85K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
Medicalcentral
|
1.0K |
418K |
44 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
44
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Drilling Confirms Significant Extension at Korbel Main
|
|
Medicalcentral
|
161 |
67K |
24 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
161
|
67K
|
24
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Drilling Confirms Significant Extension at Korbel Main
|
|
Medicalcentral
|
161 |
67K |
15 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
161
|
67K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Medicalcentral
|
13K |
5.0M |
5 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
Medicalcentral
|
811 |
334K |
68 |
22/11/20 |
22/11/20 |
ASX - By Stock
|
811
|
334K
|
68
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Q1 Financial Results and Operational Highlights
|
|
Medicalcentral
|
9 |
3.6K |
1 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
9
|
3.6K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update and Financial Results Webcast
|
|
Medicalcentral
|
51 |
19K |
5 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
51
|
19K
|
5
|
|
ASX - By Stock
|
NVA |
Re:
Re: NVA $1.00 SP 2021
|
|
Medicalcentral
|
361 |
157K |
0 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
361
|
157K
|
0
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Pause in Trading
|
|
Medicalcentral
|
24 |
9.1K |
5 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
24
|
9.1K
|
5
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Pause in Trading
|
|
Medicalcentral
|
24 |
9.1K |
4 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
24
|
9.1K
|
4
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Pause in Trading
|
|
Medicalcentral
|
24 |
9.1K |
0 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
24
|
9.1K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID-19 ARDS & GVHD Update, Quarterly Report & Appendix 4C
|
|
Medicalcentral
|
159 |
62K |
52 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
159
|
62K
|
52
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID-19 ARDS & GVHD Update, Quarterly Report & Appendix 4C
|
|
Medicalcentral
|
159 |
62K |
14 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
159
|
62K
|
14
|
|
ASX - By Stock
|
TPC |
Re:
Ann: Dividend/Distribution - TPC
|
|
Medicalcentral
|
34 |
8.2K |
0 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
34
|
8.2K
|
0
|
|
ASX - By Stock
|
BWX |
Re:
Ann: Change in substantial holding
|
|
Medicalcentral
|
6 |
1.6K |
1 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
6
|
1.6K
|
1
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Estelle Gold District Presentation - October 2020
|
|
Medicalcentral
|
65 |
24K |
3 |
19/10/20 |
19/10/20 |
ASX - By Stock
|
65
|
24K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Medicalcentral
|
17K |
6.7M |
4 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
Medicalcentral
|
1.0K |
502K |
4 |
11/10/20 |
11/10/20 |
ASX - By Stock
|
1.0K
|
502K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Medicalcentral
|
17K |
6.7M |
15 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
17K
|
6.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
Medicalcentral
|
1.0K |
502K |
7 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
1.0K
|
502K
|
7
|
|
ASX - By Stock
|
MSB |
Ruxolitinib vs Ryoncil
|
|
Medicalcentral
|
6 |
3.3K |
14 |
04/10/20 |
04/10/20 |
ASX - By Stock
|
6
|
3.3K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
Medicalcentral
|
854 |
430K |
33 |
26/09/20 |
26/09/20 |
ASX - By Stock
|
854
|
430K
|
33
|
|
ASX - By Stock
|
PAR |
Re:
Where is the green?
|
|
Medicalcentral
|
248 |
105K |
0 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
248
|
105K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
Medicalcentral
|
854 |
430K |
27 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
854
|
430K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
Medicalcentral
|
854 |
430K |
58 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
854
|
430K
|
58
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Medicalcentral
|
17K |
6.7M |
0 |
29/08/20 |
29/08/20 |
ASX - By Stock
|
17K
|
6.7M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Medicalcentral
|
17K |
6.7M |
31 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
17K
|
6.7M
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Chances of Covid Trial being a success
|
|
Medicalcentral
|
101 |
56K |
8 |
22/08/20 |
22/08/20 |
ASX - By Stock
|
101
|
56K
|
8
|
|
ASX - By Stock
|
BWX |
Re:
Ann: Results of Share Purchase Plan
|
|
Medicalcentral
|
24 |
5.1K |
0 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
24
|
5.1K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
Medicalcentral
|
2.0K |
689K |
1 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
689K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
Medicalcentral
|
2.0K |
689K |
1 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
689K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
Medicalcentral
|
2.0K |
689K |
0 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
689K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
Medicalcentral
|
2.0K |
689K |
1 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
689K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
Medicalcentral
|
2.0K |
689K |
8 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
2.0K
|
689K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
Medicalcentral
|
491 |
193K |
15 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
491
|
193K
|
15
|
|
ASX - By Stock
|
BWX |
Re:
Ann: Placement Completion
|
|
Medicalcentral
|
25 |
7.9K |
0 |
19/07/20 |
19/07/20 |
ASX - By Stock
|
25
|
7.9K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Medicalcentral
|
17K |
6.7M |
13 |
19/07/20 |
19/07/20 |
ASX - By Stock
|
17K
|
6.7M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Medicalcentral
|
20 |
9.8K |
28 |
27/05/20 |
27/05/20 |
ASX - By Stock
|
20
|
9.8K
|
28
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Medicalcentral
|
23K |
13M |
5 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
A Bigger Cash Cow for Revascor?
|
|
Medicalcentral
|
45 |
25K |
25 |
10/05/20 |
10/05/20 |
ASX - By Stock
|
45
|
25K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ann: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
|
|
Medicalcentral
|
188 |
77K |
2 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
188
|
77K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Medicalcentral
|
17K |
6.7M |
7 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
You wanna play with FIRE?
|
|
Medicalcentral
|
132 |
70K |
19 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
132
|
70K
|
19
|
|
ASX - By Stock
|
MSB Biotech |
Re:
Chat thread
|
|
Medicalcentral
|
185 |
74K |
39 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
185
|
74K
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Gilead vs Mesoblast
|
|
Medicalcentral
|
274 |
111K |
26 |
19/04/20 |
19/04/20 |
ASX - By Stock
|
274
|
111K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Medicalcentral
|
5.4K |
2.6M |
31 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
5.4K
|
2.6M
|
31
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Medicalcentral
|
23K |
13M |
2 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Medicalcentral
|
23K |
13M |
5 |
22/01/20 |
22/01/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
Medicalcentral
|
4.4K |
2.4M |
0 |
13/09/19 |
13/09/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
0
|
|